Nearly all of us use and depend on computers for running and operatingour medical offices. I doubt that many of us could successfully operateour practices without this evolving technology, which adds not only to improvementin the medical care we offer our patients but to the efficiency of our practices.
Dr. Schuster highlights the FDA approval of imaging agent flotufolastat F 18 in prostate cancer
June 22nd 2023"We're excited that the FDA approval of this radiotracer gives us yet more tools at our disposal to diagnose prostate cancer in all its forms, from early to late in the disease process," says David M. Schuster, MD, FACR.